Michael Lübbert

16PUBLICATIONS
114CO-AUTHORS
Gene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedMolecular targetsHaematological tumoursAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 03, 2026
Increase in fetal haemoglobin from baseline to day 10 is a biomarker for response to decitabine in AML: Results of the AML21 randomized phase III trial of the EORTC Leukemia Group, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) and German MDS Study Group.

|Mar 10, 2026
Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

Dorothée Selimoglu-Buet, Sylvie Chevret, Valeria Santini

|Nov 08, 2025
DNA methyltransferase inhibitors in hematological malignancies and solid tumors.

Valentin Wenger, Guillermo Garcia-Manero, Robert Zeiser

|Apr 04, 2025
Therapeutic targeting of chromatin alterations in leukemia and solid tumors.

Florian Perner, Tobias Berg, Daniel Sasca

|Mar 31, 2025
Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.

Etienne Sollier, Anna Riedel, Umut H Toprak

|Nov 26, 2024
Genocopy of EVI1-AML with paraneoplastic diabetes insipidus: PRDM16 overexpression by t(1;2)(p36;p21) and enhancer hijacking.

Julian List, Etienne Sollier, Fiona Brown-Burke

Pageof 3

Frequent Collaborators

5 joint publications

Julia Stomper

4 joint publications

Hartmut Döhner

3 joint publications

Christoph Plass

3 joint publications

Michael Heuser